Back to search

United Kingdom· GB-APID-422611000001106

Fenbufen 300mg tablets

A fenbufen product containing fenbufen, registered in United Kingdom by Kent Pharma (UK) Ltd.

ATC M01AE05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedFenbufen 300mg tabletsATCM01AE05REGISTER NO.GB-APID-4226110000011…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Fenbufen
Manufacturer
Kent Pharma (UK) Ltd
Country
United Kingdom (GB)
ATC code
M01AE05
ATC class
Fenbufen
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b2b9d609-d8a6-4cfd-9683-a847d23794c6
GET /v1/drugs/b2b9d609-d8a6-4cfd-9683-a847d23794c6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "422611000001106",
  "desc": "Fenbufen 300mg tablets (Kent Pharma (UK) Ltd)",
  "form": "Oral tablet",
  "vpid": "42103811000001106",
  "source": "dmd",
  "vtm_id": "775926008",
  "strength": "300 mg",
  "substance": "Fenbufen",
  "ingredient": "Fenbufen",
  "supplier_code": "2073701000001100"
}

See everything about fenbufen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.